Facebook promised Biden regime “any messaging you want” in newly released emails… asked for talking points on COVID vaccines
By News Editors // Jan 11, 2023

In April 2021, the U.S. Centers for Disease Control (CDC) and the Food and Drug Administration (FDA) issued a statement pausing the administration of the Johnson & Johnson Covid-19 vaccine after it caused severe blood clotting in 6 female recipients. After this news broke, Facebook contacted the Biden regime to ensure them that the social media platforms would “amplify any messaging” to convince the public the shot was safe and effective.

(Article by Amber Crawford republished from 100PercentFedUp.com)

The New Civil Liberties Alliance (NCLA) is currently part of a lawsuit that was filed by the Attorneys General of Louisiana and Missouri which alleges improper collusion between the federal government and social media companies. The emails between Facebook and the White House were obtained in discovery.

In their communications with the White House, Facebook asked how they could “get ahead” of possible doubt or fear arising in the general public about Covid vaccines.

One employee – whose name is redacted due to a court order – sent a message to Andrew Slavitt, the Biden administration’s senior advisor for the Covid response, along with Director of Digital Strategy Rob Flaherty and Director of Strategic Communications and Engagement for the Covid-19 Response Team Courtney Rowe. In the email, the employee wrote,

“Re the J+J news, we’re keen to amplify any messaging you want us to project about what this means for people – it obviously has the risk of exacerbating vaccine hesitancy, so we’re keen to get ahead of the knock-on effect. Don’t hesitate to tell me – or via your teams – how we can help to provide clarity/reassurance via Facebook.”

In response to the email, Flaherty gave the employee some suggestions on how Facebook could shut down anyone questioning the safety of the vaccine, such as telling users that “adverse effects are very rare.” Flaherty also requested a “commitment from [Facebook] to make sure that a favorable review [of the vaccine] reaches as many people as the pause, either through hard product interventions or algorithmic amplification,” ensuring that “the news about J&J doesn’t spin off misinformation.”

In another email between Facebook and the Biden administration, the employee told Flaherty that the social media company would “love to talk” about ways they could adjust its algorithm to control what information is shared and what is primarily hidden from public view, ensuring that the White House has control over the dominant messaging surrounding the vaccines.

Facebook worked with the federal government to only share approved messaging about the Covid-19 vaccines, silencing anyone who questioned the safety of the shots or suggested they may cause serious side effects.

Although the government tried shutting down anyone who said the vaccine is not safe, in May 2022 the FDA ended up limiting the use of the J&J vaccine only to those who were unable or refused to take another vaccine due to the risk of blood clots, suggesting that those who questioned the vaccine’s safety were right to do so.

Read more at: 100PercentFedUp.com



Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.